Aller au contenu principal
Retour à l'annuaire
Rhumatologue

Docteur PIERRE SALLE

RPPS 10003044947
📊 Reconnaissance scientifique : 1/100📝 10 articles publiés📚 HAL (1)

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

🏅 DU / DIU

  • Diplôme relatif à la Réparation juridique du dommage corporel

📚 CES (Certificat d'Études Spéciales)

  • CES Rhumatologie
  • CES Médecine légale

🎯 Capacités

  • Médecine légale (C)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

1

h articles cités ≥ h fois chacun. Un h de 1 = 1 publications avec 1+ citations.

Citations

3

Publications

10

i10-index

0

Thématiques principales

  • Historical Studies and Socio-cultural Analysis ×3
  • Medieval Literature and History ×2
  • Health, Medicine and Society ×2
  • Archaeology and Historical Studies ×2
  • Healthcare Systems and Practices ×2

Affiliations FR : Centre National de la Recherche Scientifique · École Normale Supérieure - PSL · École Nationale des Chartes

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (2)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

  • Brouard livre sa liste - Sud Ouest

    📰 Sud Ouest · 19/01/2013

    <a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOR2hIWm5vWlFsOTdGckYzdW1UcktNRmprbllDNlRVNnZUY0NjVi1CN05hYTlWTTJjUnI5djdLVHBUWU9sREdLaTBudFlkOUtGaVlxaEtEYXQxUGY5RUlqMUJVSm1BbnNPaWZhWkpVbkpjLUtTU21Ka1Jja200UHZibUIyVVlnT010Vk1LUmVnVFRtMTFadE5maXZ1SmZ2NzZmTjYw?oc=5" target="_blank">Brouard

  • Une soirée pour saluer les pionniers et les survivants du sida - Fugues

    📰 Fugues · 26/11/2021

    <a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOZllrOVBULXN1bVNhNWU3b1F0ek5Id2dCb0pmbUVLdWNRenNSOVo0Wm1lT190dU93cUpqMzgwSDVtTGdQV3p0Y3FxSFE3RDhtd3NOWV9hdERYVHFSRUpIaDY3N0dEYVVFSjlHM01sc0M2M1NId2E5ekhmRS15OGhJVlZkeXFzU3IzMWc2M2xabFNTYUVHVkV4OE9fTkVCZw?oc=5" target="_blank">Une soirée po

Top publications · les plus citées

  • 1
    Generic Theoretical Models to Predict Division Patterns of Cleaving Embryos

    Developmental cell · 2016

    📚 48 citations🎯 RCR 1.45🔓 Open Access
  • 2
    Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases

    Seminars in arthritis and rheumatism · 2017

    📚 22 citations🎯 RCR 1.40
  • 3
    Efficacy of Intra-Articular Botulinum Toxin in Osteoarticular Joint Pain: A Meta-Analysis of Randomized Controlled Trials

    The Clinical journal of pain · 2018

    📚 16 citations🎯 RCR 1.27
    Lire l'abstract Crossref ↓

    Objective: This study was conducted with the aim of evaluating the efficacy of intra-articular injections of botulinum toxin type A (BT-A) into the painful joint diseases through a systematic review of the literature and a meta-analysis of controlled randomized trials. Intra-articular therapies (corticosteroids, hyaluronic acid) have limited efficacy and run a risk of toxicity in patients with joint pain. New therapeutic options are needed to treat painful osteoarticular disease. Methods: We searched via Pubmed, American College of Rheumatology, and European League Against Rheumatism congresses, and gray literature for the studies reported until June 2016 and addressing the issue of BT intra-articular injections in patients with refractory joint pain. Randomized trials were included. For the meta-analysis, we compared a numeric rating scale (NRS) from 0 to 10 before treatment and at 1 or 2 months and 6 months after in the BT-A and the control groups for each study. We also compared separately low dose and high dose of BT at 1 or 2 months’ evaluation. Results: In a total of 269 selected articles, 8 were analyzed and 6 studies were included in the meta-analysis involving a total of 382 patients. On comparing the NRS rating for 5 trials, at 1 or 2 months irrespective of the dose of BT, 4 trials showed a positive effect of BT compared with the control on the NRS and 1 found no effect; the overall weighted mean difference [95% confidence interval (CI)] was −1.10 (−1.62, −0.58) (P&lt;0.0001, I 2=63%). Among the 4 trials with a low dose of BT (100 U), comparing NRS at 1 or 2 months, 3 trials showed significant results with a positive effect of BT-A injection compared with the control on the NRS; the fourth study failed to find any effect. The overall weighted mean difference (95% CI) was −0.95 (−0.02, −1.88) (P=0.05, I 2=67%). In the 2 trials using a high dose of BT (200 U) comparing NRS at 1 or 2 months, there was an almost zero effect of BT, with an overall weighted mean difference (95% CI) of 0.13 (−0.55, 0.81) (P=0.71, I 2=0%). In the 3 trials comparing NRS at 6 months there was an overall weighted mean difference (95% CI) of −0.57 (−1.98, 0.83) (P=0.42, I 2=73%). Conclusions: BT-A intra-articular injections have short-term benefits with a statistically significant decrease in the NRS pain score of around 1 point in patients with refractory joint pain. A decrease in the pain score was also observed at 6 months but with a nonsignificant result.

Publications scientifiques (5) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal4

Essai clinique1

Revue / méta-analyse1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.